Trevena Inc. (TRVN) |
|
0.7517 -0.018 (-2.36%)
|
02-21 16:00 |
|
Open: |
0.7644 |
Pre. Close: |
0.7699 |
|
High:
|
0.7699 |
Low:
|
0.74 |
|
Volume:
|
461,970 |
Market Cap:
|
70M |
|
|
|
|
Trevena Inc is a clinical stage biopharmaceutical company. It discovers, develops and commercialize therapeutics that use a novel approach to target G protein coupled receptors. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.771 - 0.775 |
0.775 - 0.778 |
|
Low:
|
0.731 - 0.735 |
0.735 - 0.739 |
|
Close:
|
0.743 - 0.75 |
0.75 - 0.757 |
|
Technical analysis |
as of: 2020-02-21 4:34:32 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 1.04 One year: 1.16 |
| Support: |
Support1: 0.73 Support2: 0.61 |
| Resistance: |
Resistance1: 0.89 Resistance2: 0.99 |
| Pivot: |
0.81 |
| Moving Average: |
MA(5): 0.76 MA(20): 0.84
MA(100): 0.83 MA(250): 1.05 |
| MACD: |
MACD(12,26): -0.03 Signal(9): -0.01 |
| Stochastic oscillator: |
%K(14,3): 15.29  %D(3): 12.57 |
| RSI: |
RSI(14): 37.77 |
| 52-week: |
High: 2.00 Low: 0.60 Change(%): -47.4 |
| Average Vol(K): |
3-Month: 58097 10-Days: 64352 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.TRVN has closed above bottom band by 20.4%. Bollinger Bands are 8.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Thu, 11 Jan 2018 08:18:28 +0000
7 High-Risk, High-Reward Stocks to Buy Now
Tue, 01 Sep 2015 05:12:56 +0000
Mid-Day Market Update: Crude Oil Dips Over 6%; Matrix Service Shares Rise On Earnings Beat
Tue, 01 Sep 2015 14:31:38 +0000
Mid-Morning Market Update: Markets Open Lower; Dollar Tree Posts Q2 Loss
Tue, 19 Mar 2019 09:53:00 +0000
Puma Biotech's (PBYI) Nerlynx Gets Approval in Australia
Fri, 15 Mar 2019 15:25:00 +0000
PDL BioPharma (PDLI) Q4 Earnings Top Mark, Revenues Fall Y/Y
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
